Iradimed (IRMD) Cash from Investing Activities Growth (3y) (2016 - 2026)
Iradimed (IRMD) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | -17.67% |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | -5.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.40% |
| Mar 31, 2026 | 58.49% |
| Dec 31, 2025 | 4.07% |
| Sep 30, 2025 | -31.46% |
| Jun 30, 2025 | -237.40% |
| Mar 31, 2025 | -109.71% |
| Dec 31, 2024 | -139.67% |
| Sep 30, 2024 | -162.97% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -40.15% |
| Dec 31, 2023 | -60.13% |
| Sep 30, 2023 | -58.40% |
| Jun 30, 2023 | -49.13% |
| Mar 31, 2023 | -205.32% |
| Dec 31, 2022 | -35.80% |
| Sep 30, 2022 | -34.00% |
| Jun 30, 2022 | -38.86% |
| Mar 31, 2022 | -40.31% |
| Dec 31, 2021 | -37.70% |
| Sep 30, 2021 | -32.83% |